Speculative growth has been the strongest theme into the end of the year.
But interestingly, we're noticing a major divergence between U.S. growth and E.M. growth. While the former is at the top of the rankings, E.M. growth has transitioned to red.
We need to see the Emerging Market Internet ETF $EMQQ reclaim this breakout level if we want to have a more positive stance on this theme.
Weโve noticed a significant shift in both Large Cap Technology ($XLK) and Equal Weight Technology ($RSPT), as they transition from red to deeper shades of green, as illustrated below.
This suggests a resurgence of growth leadership heading into 2025.
From a technical perspective, the breakout of the Large Cap Technology ETF ($XLK) from a six-month base further supports this trend.
With this setup, thereโs considerable potential for technology to push higher as we move into the new year.
We're seeing a stronger performance in larger stocks and those within the growth factor, with more of them in the green compared to smaller and value stocks.
This is especially clear in the Small Cap ETF ($IWM), which recently failed at a key level of resistance.The Vanguard FTSE Europe ETF ($VGK) breaking down to fresh lows is particularly concerning. A swift recovery here is essential to shift the narrative.
Typically, after a rejection like this, we tend to see a period of sideways movement as the market absorbs overhead supply before the next move higher.
I've noticed that the technology sector ETFs have turned from red (or light green) to a darker shade of green.
This makes sense with growth picking up steam while value has cooled off.
All technology sector ETFs look prime to break to new highs. While larger technology companies have outperformed, it's positive for the sector to see all three at their highest level they've been all year.
It's a new year and the market is looking forward.
It doesn't matter what happened last year, as far as our decisions are concerned. But let's not forget that humans are irrational, and they will certainly let the past year or two impact their decision making.
They can't help themselves. So it's up to us as traders and investors to extract those dollars for our own selfish reasons.
We're here to make money. Period. Taking advantage of human flaws is a great way to do that, as I've been showing you here every day for over a decade.
Yesterday we discussed the irrational behavior we're seeing from investors in the middle of a bull market. They're running scared, just as market breadth is improving to the upside, across multiple timeframes.
The Retail Investors are scared to death. And that's a good thing.
We don't want individual investors too optimistic. That's when stocks sell off. It's when they're pessimistic and worried that you see the best forward returns.
Go back and see for yourself. It's all public information. These are the people we want to fade. This is the "Dumb" money, so to speak.
Dig this. The first sentiment data for the year just came out from the American Association of Individual Investors with the fewest number of bulls since April of last year.
In the middle of the bull market, they're crazy scared.
Good.
Now keep in mind, this is specifically what they're saying.
But what are they doing?
Well, the Put/Call Ratio just hit new 4-month highs. This means investors are buying insurance (Put options) at a much faster rate than they're betting on higher stock prices (Call options).
That's also evidence that they're scared. Why else would you be buying insurance at such a fast rate?
Now, what else are they doing?
Active Investment Managers (NAAIM) have on the least amount of long exposure since...
Today's trade is in a stock who's price action is mimicking what their products delivers for its customers -- it's going vertical! How's that for kizmet?
That trade might classify as a "hard trade," but I'll be doing what I can to increase the odds of success in my favor.
Our International Hall of Famers list is composed of the 100 largest US-listed international stocks, or ADRs.
We've also sprinkled in some of the largest ADRs from countries that did not make the market cap cut.
These stocks range from some well-known mega-cap multinationals such as Toyota Motor and Royal Dutch Shell to some large-cap global disruptors such as Sea Ltd and Shopify.
It's got all the big names and moreโbut only those that are based outside the US. You can find all the largest US stocks on our original Hall of Famers list.
The beauty of these scans is really in their simplicity.
We take the largest names each week and then apply technical filters in a way that the strongest stocks with the most momentum rise to the top.
Based on the market environment, we can also flip the scan on its head and filter for weakness.
Let's dive in and take a look at some of the most important stocks from around the world.
Todayโs most notable transaction comes via a Form 4 filing by EcoR1 Capital LLC, a biotech-focused hedge fund known for its expertise in high-growth life sciences investments.
The fund revealed a purchase of 363,369 shares of Zymeworks Inc $ZYME, equivalent to $5,321,175. EcoR1โs ownership stake in ZYME is now 22.04%.
Hereโs The Hot Corner, with data from January 2, 2024:
But it doesn't end there. EcoR1 Capital also stepped in for a purchase of AnaptysBio $ANAB shares with a total value of $1,099,642. ANAB is now the largest holding in EcoR1โs portfolio.